作者
Dahham Alsoud, Gert De Hertogh, Griet Compernolle, Sophie Tops, João Sabino, Marc Ferrante, Debby Thomas, Séverine Vermeire, Bram Verstockt
发表日期
2022/10
期刊
Journal of Crohn's and Colitis
卷号
16
期号
10
页码范围
1562–1570
出版商
Oxford University Press
简介
Background
Histo-endoscopic outcomes are being proposed as new treatment targets in ulcerative colitis [UC]. Little is known about the pharmacokinetic-pharmacodynnamic [PK-PD] relationship of ustekinumab [UST] in UC patients or whether serum UST concentrations reflect tissue drug exposure. We aimed to study UST serum concentrations and their relation to tissue exposure and drug effectiveness in a real-world setting.
Methods
A total of 42 UC patients starting UST were prospectively followed by clinical, endoscopic and histological assessments at Week 16. Histological remission was defined as Nancy Histology Index of 0. Analogous to the UNIFI programme, histo-endoscopic mucosal improvement was defined as a combination of histological improvement [Geboes ≤3.1] and endoscopic improvement [MES ≤1]. Paired trough serum samples and colonic mucosal …
引用总数